Molecular Templates, Inc. - FORM 10-K - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - March 8, 2010

Attached files

file filename
10-K - FORM 10-K - Molecular Templates, Inc.d10k.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.dex321.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - Molecular Templates, Inc.dex322.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 15D 14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.dex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 15D 14 OF THE SECURITIES AND EXCHANGE ACT OF 1934 - Molecular Templates, Inc.dex311.htm
EX-10.25 - WAIVER OF RIGHTS - Molecular Templates, Inc.dex1025.htm
EX-10.26 - EXCLUSIVE LICENSE AGREEMENT DATED OCTOBER 14, 2009 - Molecular Templates, Inc.dex1026.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-162719 and 333-153475) and Registration Statement on Form S-8 (No. 333-164865, No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) of Threshold Pharmaceuticals, Inc. of our report dated March 8, 2010 relating to the consolidated financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 8, 2010

Stock widget

Investing forum

Molecular Templates, Inc. Reports